Sobue Satoshi, Sekiguchi Kaneo, Nabeshima Toshitaka
Department of Clinical Pharmacology, Pfizer Global R & D, Tokyo Laboratories, Pfizer Japan Inc., Tokyo, Japan.
Antimicrob Agents Chemother. 2004 Jan;48(1):216-23. doi: 10.1128/AAC.48.1.216-223.2004.
We have compared the distribution of fluconazole (FLC) with that of itraconazole (ITC) and griseofulvin (GRF) in the abdominal skin tissues after a single oral dose was administered to guinea pigs. The FLC concentrations in the stratum corneum reached a peak at 2 h after administration and were similar to those of ITC and higher than those of GRF in spite of the administration of a lower dose. GRF was eliminated from the stratum corneum faster than FLC and ITC. The FLC concentrations were also remarkably higher than those of ITC and GRF in the epidermis-cutis but lower in the subcutaneous fatty tissue. The distribution characteristics of each drug result from differences in their physicochemical properties. Following the administration of multiple doses, the FLC concentrations in the stratum corneum were highest in the abdominal skin tissues; those at 24 h after each administration increased gradually and were maintained at a level more than 10 times higher than that of the plasma concentrations. The FLC concentrations in the planta pedis stratum corneum and in the nail showed good dose proportionality and obvious accumulation and were 60 and 40 times as high as that in plasma on day 14. The extent of binding of FLC to human corneous keratin in vitro was about 10%, which is lower than those of ITC (94 to 97%) and GRF (36 to 38%). FLC, unlike ITC, therefore, is presumed to exist in the stratum corneum at high concentrations in an active nonbinding form. These excellent intracutaneous pharmacokinetic properties of FLC probably account in large part for the in vivo efficacy of FLC.
我们比较了豚鼠单次口服给药后,氟康唑(FLC)、伊曲康唑(ITC)和灰黄霉素(GRF)在腹部皮肤组织中的分布情况。尽管氟康唑给药剂量较低,但角质层中的氟康唑浓度在给药后2小时达到峰值,与伊曲康唑相似且高于灰黄霉素。灰黄霉素从角质层中的消除速度比氟康唑和伊曲康唑快。表皮-真皮中的氟康唑浓度也显著高于伊曲康唑和灰黄霉素,但在皮下脂肪组织中较低。每种药物的分布特征源于其理化性质的差异。多次给药后,腹部皮肤组织中角质层的氟康唑浓度最高;每次给药后24小时的浓度逐渐升高,并维持在比血浆浓度高10倍以上的水平。足底角质层和指甲中的氟康唑浓度呈现良好的剂量比例关系和明显的蓄积现象,在第14天时分别是血浆浓度的60倍和40倍。体外实验中,氟康唑与人角质角蛋白的结合程度约为10%,低于伊曲康唑(94%至97%)和灰黄霉素(36%至38%)。因此,与伊曲康唑不同,推测氟康唑以高浓度的活性非结合形式存在于角质层中。氟康唑这些优异的皮内药代动力学特性可能在很大程度上解释了其体内疗效。